NINDS Efficacy and Exploratory Clinical Trials (UG3/UH3 - Clinical Trial Required)

Posted

National Institutes of Health

Description

This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). These trials must address questions within the mission and research interests of the NINDS and may include studies of small molecules, biologics, devices as well as surgical, behavioral, diet-based, or rehabilitation therapies. Studies addressing neurological diseases and care across the lifespan are highly encouraged. This notice invites both early- and middle-phase exploratory clinical trials as well as later phase confirmatory Phase 3 or comparative effectiveness clinical trials.

Who can apply

  • State governments
  • County governments
  • City or township governments
  • Special district governments
  • Independent school districts
  • Public and State controlled institutions of higher education
  • Native American tribal governments (Federally recognized)
  • Public housing authorities / Indian housing authorities
  • Native American tribal organizations (other than Federally recognized)
  • Nonprofits with 501(c)(3) status (other than higher education)
  • Nonprofits without 501(c)(3) status (other than higher education)
  • Private institutions of higher education
  • For-profit organizations other than small businesses
  • Small businesses
  • Others

Contact

Exploratory_Efficacy_Trials@ninds.nih.gov<br/>Exploratory_Efficacy_Trials@ninds.nih.gov
Exploratory_Efficacy_Trials@ninds.nih.gov

Key dates & funding
  • PostedAug 31, 2026
  • ClosesMar 9, 2029
  • CFDA93.853
Categories

Get more from this grant

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — available free when you're signed in.

Sign in to use tools